Wiring the Infant Brain: The Neuroscience of Essential Vitamins
- Jessica Atkins, Dev Psychologist

- Sep 25, 2025
- 7 min read

From a neuroscientific perspective, the infant brain is the body’s most energy-intensive organ, consuming nearly 60% of basal metabolic energy in early life. This extraordinary demand reflects rapid neurogenesis, myelination, synaptogenesis, and pruning—the cellular events that lay the foundations for cognition, emotion regulation, and behavior. While macronutrients provide bulk energy, several vitamins and lipids function as catalysts and structural elements in neural development. Six stand out for their direct neurobiological roles: vitamin D, iron, folate, vitamin B₁₂, choline, and docosahexaenoic acid (DHA). This article synthesizes on how each shapes infant brain architecture and function, with direct implications for clinical practice and parental decision-making.
Vitamin D: A Neuro-steroid for Early Circuits
Vitamin D is traditionally viewed as a skeletal nutrient, yet it acts at the molecular level as a neurosteroid. Vitamin D receptors (VDRs) are expressed in the hippocampus, thalamus, cerebellum, amygdala, and cortex, regions critical for memory, attention, and emotional regulation (link).
Mechanisms: Vitamin D regulates serotonin and dopamine synthesis, modulates calcium signaling, and influences apoptosis and neuronal differentiation (link).
Clinical impact: Maternal deficiency (<50 nmol/L 25(OH)D) is associated with poorer infant mental development scores and increased risk of later schizophrenia and autism (link).
Prevalence: A meta-analysis of ~8 million participants found 15.7% deficiency (<30 nmol/L) and 47.9% insufficiency (<50 nmol/L) worldwide (link).
Guidance: Because breast milk is low in vitamin D, pediatric guidelines recommend 400 IU/day supplementation for breast-fed infants.
Adequate vitamin D helps regulate infant sleep, mood stability, and motor development. Supplementation is non-negotiable—even in sunny climates—due to limited skin exposure and pigmentation effects.
Iron: Wiring Speed and Monoamine Balance
Iron is one of the most critical micronutrients for the developing brain, supporting energy production, neurotransmitter synthesis, and the construction of myelin. At the cellular level, iron functions as a cofactor in the electron transport chain, enabling neurons to generate the ATP required for rapid growth and synaptic activity. It is also necessary for enzymes that synthesize dopamine, norepinephrine, and serotonin—neurotransmitters central to attention, emotional regulation, and impulse control (link). Beyond neurotransmission, iron fuels the proliferation of oligodendrocytes, the glial cells responsible for producing myelin. Myelin acts as insulation around axons, allowing neural signals to travel quickly and efficiently.
When iron levels are insufficient during critical windows of brain development, the result is slowed conduction speed and diminished integration across brain networks (link). Clinically, iron deficiency in late gestation and the first two years of life has been associated with smaller hippocampal volume, delayed myelination, and altered synaptic plasticity. These biological changes often manifest as slower cognitive processing, weaker working memory, increased anxiety, and reduced impulse control in children (link). The risk is especially high in premature or low-birthweight infants, who miss the majority of maternal iron transfer that occurs during the third trimester. Exclusively breast-fed infants are also vulnerable, since breast milk naturally contains limited iron. If maternal anemia is present during pregnancy, the infant’s starting iron stores may be further compromised.
For these reasons, the American Academy of Pediatrics recommends that exclusively breast-fed infants receive 1 mg/kg/day of oral iron supplementation beginning at four months of age, continuing until iron-rich complementary foods are introduced. By six months, iron-rich foods such as puréed meats, fortified cereals, beans, and egg yolks become essential. This period coincides with peak brain myelination between six and twelve months, making iron sufficiency especially critical for supporting both cognitive growth and emotional stability. Parents may worry about side effects such as constipation or taste, but the risks of leaving iron deficiency untreated—long-term impacts on learning, behavior, and emotional regulation—are far greater.
Folate and Vitamin B₁₂: The Methylation Partners
Folate (vitamin B₉) and vitamin B₁₂ (cobalamin) function together in one-carbon metabolism, a biochemical pathway that supplies methyl groups for DNA and histone methylation, neurotransmitter production, and nucleotide synthesis. These processes are fundamental to neurogenesis, synaptic plasticity, and myelination in the developing brain. Folate deficiency during pregnancy is widely known for causing neural tube defects, but its role extends far beyond embryonic closure. Low folate levels in late gestation and infancy can impair hippocampal neurogenesis, reduce synaptic connectivity, and predispose children to later difficulties in memory, learning, and mood regulation (link). Vitamin B₁₂ works hand-in-hand with folate, particularly in the recycling of homocysteine to methionine, which produces S-adenosylmethionine (SAM)—the universal methyl donor required for gene expression and myelin maintenance.
Without sufficient B₁₂, methylation reactions falter, resulting in delayed myelination or even demyelination. Clinically, infants with B₁₂ deficiency may present with hypotonia, apathy, irritability, developmental regression, or seizures. These symptoms highlight the vitamin’s direct influence on both motor development and emotional regulation. The risk is heightened in infants born to vegan mothers, since B₁₂ is found almost exclusively in animal products, making maternal supplementation or fortified infant formula essential. From a public health standpoint, periconceptional folic acid supplementation of 400 µg/day remains one of the most successful nutritional interventions, reducing neural tube defects by nearly two-thirds.
For newborns, folate adequacy typically depends on maternal status and fortified formula, while breast milk generally provides sufficient folate if the mother’s stores are adequate. Vitamin B₁₂, however, cannot be assumed sufficient in exclusively breast-fed infants if the mother follows a strict plant-based diet. Pediatricians may recommend maternal supplementation during pregnancy and lactation or direct infant supplementation in high-risk cases.
For parents, the implication is clear: folate and B₁₂ are not just “vitamins for pregnancy”—they remain critical in infancy for wiring memory systems, stabilizing mood, and supporting the integrity of myelin.


Comments